Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania
- 155 Downloads
Previous trials of selective serotonin reuptake inhibitors (SSRIs) in the treatment of trichotillomania have provided conflicting data. Furthermore, the efficacy of citalopram, the most selective of the SSRIs, in trichotillomania has not previously been documented. Citalopram was used on an open-label naturalistic basis in 14 (1 male and 13 females) patients who presented with chronic hair pulling and met DSM-IV criteria for trichotillomania. Ratings were completed every 2 weeks for 12 weeks, during which time dosage was increased to a maximum of 60 mg daily (mean dose 36.2 ± 13.9 mg). One patient was unable to tolerate citalopram. In completers, ratings on each of the scales employed were significantly improved after treatment. Of completers 38.5% were responders (Clinical Global Impressions score of 2 or less) at week 12. Citalopram appears to be safe in trichotillomania, and it may be effective in a subset of patients. Given the relatively low response rate, however, a controlled trial is needed before this agent can be said to be more effective than placebo. The pharmacotherapy of trichotillomania deserves further study.
Key wordsTrichotillomania Selective serotonin reuptake inhibitor Citalopram
Unable to display preview. Download preview PDF.
- 1.Hallopeau M (1889) Alopecia par grottage (trichomania ou trichotillomania). Annales Dermatol Venerol 10:440–441Google Scholar
- 2.Christenson GA, Pyle RL, Mitchell JE (1991) Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry 525:415–417Google Scholar
- 4.Swedo SE (1993) Is trichotillomania an obsessive-compulsive spectrum disorder? In: Hollander E (ed) The Obsessive-Compulsive related disorders. American Psychiatric Press Washington, DCGoogle Scholar
- 5.Stein DJ, Simeon D, Cohen LJ, Hollander E (1995) Trichotillomania and obsessive-compulsive disorder. J Clin Psychiatry 565:28–34Google Scholar
- 10.Benarroche CL (1990) Trichotillomania symptoms and fluoxetine response. Paper presented at the 143rd Annual Meeting of the American Psychiatric Association, New York, May 1990Google Scholar
- 16.Montgomery SA, Pedersen V, Tanghoj P, Rasmussen C, Rioux P (1994) The optimal dosing regime for citalopram: a metaanalysis of nine placebo-controlled studied. Int Clin Psychopharmacol 9S:35–40Google Scholar
- 17.Bejerot S, Humble M (1991) Citalopram treatment of obsessive-compulsive disorder: a pilot study of antiobsessive efficacy. Biol Psychiatry 29:443Google Scholar
- 18.Stein DJ, Maud CM, Bouwer C (1996) Use of the serotonin selective reuptake inhibitor citalopram in obsessive-compulsive disorder. J Serotonin Res 1:29–33Google Scholar
- 19.American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (DSM-IV) 4th edn. American Psychiatric Press, Washington, DCGoogle Scholar
- 20.First MB, Spitzer RL, Gibbon M, Williams JB (1994) Structured Clinical Interview for Axis I DSM-IV disorders. Biometrics Research Department, New York State Psychiatric InstituteGoogle Scholar